These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6325697)

  • 21. Acquisition of susceptibility to vesicular stomatitis virus infection by murine resident peritoneal cells during culturing in vitro.
    Orzechowska B; Błach-Olszewska Z
    Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):325-8. PubMed ID: 9017147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autographa californica nucleopolyhedrovirus infection results in Sf9 cell cycle arrest at G2/M phase.
    Braunagel SC; Parr R; Belyavskyi M; Summers MD
    Virology; 1998 Apr; 244(1):195-211. PubMed ID: 9581791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of the rat in vitro plaque-forming response to sheep erythrocytes by a soluble factor(s) derived from concanavalin A-activated rat T lymphocytes.
    Teodorczyk-Injeyan JA; Falk RE
    Folia Biol (Praha); 1982; 28(4):243-54. PubMed ID: 6754468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three different signals are required for the induction of cytolytic T lymphocytes from resting precursors.
    Kanagawa O
    J Immunol; 1983 Aug; 131(2):606-10. PubMed ID: 6602842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific resistance of T cells to CD95-induced apoptosis during S phase of the cell cycle.
    Dao T; Huleatt JW; Hingorani R; Crispe IN
    J Immunol; 1997 Nov; 159(9):4261-7. PubMed ID: 9379021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-12 is not required for induction of type 1 cytokine responses in viral infections.
    Oxenius A; Karrer U; Zinkernagel RM; Hengartner H
    J Immunol; 1999 Jan; 162(2):965-73. PubMed ID: 9916721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation of memory T cells to virus plaque-forming cells and cytotoxic T lymphocytes.
    Senik A; Bloom BR
    J Exp Med; 1977 Jul; 146(1):11-21. PubMed ID: 194999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of mitogen-induced lymphocyte proliferation by ouabain: interference with interleukin 2 production and interleukin 2 action.
    Stoeck M; Northoff H; Resch K
    J Immunol; 1983 Sep; 131(3):1433-7. PubMed ID: 6604100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral T cells in mice lacking p56lck do not express significant antiviral effector functions.
    Molina TJ; Bachmann MF; Kündig TM; Zinkernagel RM; Mak TW
    J Immunol; 1993 Jul; 151(2):699-706. PubMed ID: 8393038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective triggering of apoptosis of concanavalin A-activated T cells by fraxinellone for the treatment of T-cell-dependent hepatitis in mice.
    Sun Y; Qin Y; Gong FY; Wu XF; Hua ZC; Chen T; Xu Q
    Biochem Pharmacol; 2009 Jun; 77(11):1717-24. PubMed ID: 19428326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T cell--vascular smooth muscle cell interactions: antigen-specific activation and cell cycle blockade of T helper clones by cloned vascular smooth muscle cells.
    Suttles J; Miller RW; Moyer CF
    Exp Cell Res; 1995 May; 218(1):331-8. PubMed ID: 7737369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Saikosaponin a inhibits the proliferation and activation of T cells through cell cycle arrest and induction of apoptosis.
    Sun Y; Cai TT; Zhou XB; Xu Q
    Int Immunopharmacol; 2009 Jul; 9(7-8):978-83. PubMed ID: 19375524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of vesicular stomatitis virus replication by epidermal growth factor in human epidermoid A-431 cells.
    Korutla L; Kumar R
    Biochem Biophys Res Commun; 1996 Mar; 220(3):670-4. PubMed ID: 8607823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-activation of T lymphocytes by low dose of concanavalin A aggravates toll-like receptor-3 ligand-induced NK cell-mediated liver injury.
    Wang J; Sun R; Wei H; Dong Z; Tian Z
    Int Immunopharmacol; 2006 May; 6(5):800-7. PubMed ID: 16546711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical evaluation of B cell and T-regulator cell function using a protein A haemolytic plaque assay.
    Jones BM
    Clin Exp Immunol; 1981 Oct; 46(1):196-205. PubMed ID: 6461453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CTLA4-CD80/CD86 interactions on primary mouse CD4+ T cells integrate signal-strength information to modulate activation with Concanavalin A.
    Mukherjee S; Ahmed A; Nandi D
    J Leukoc Biol; 2005 Jul; 78(1):144-57. PubMed ID: 15788440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vesicular stomatitis virus infection triggers apoptosis associated with decreased DeltaNp63alpha and increased Bax levels in the immortalized HaCaT keratinocyte cell line.
    Megyeri K; Orosz L; Kemény L
    Biomed Pharmacother; 2007 Jun; 61(5):254-60. PubMed ID: 17459650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The oncolytic effect of recombinant vesicular stomatitis virus is enhanced by expression of the fusion cytosine deaminase/uracil phosphoribosyltransferase suicide gene.
    Porosnicu M; Mian A; Barber GN
    Cancer Res; 2003 Dec; 63(23):8366-76. PubMed ID: 14678998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased adenosine deaminase (ADA) activity and a shift from ADA-dependent to ADA-independent phases during T-cell activation: a paradox.
    Veit BC; Fishman M; Look T
    J Natl Cancer Inst; 1984 May; 72(5):1151-9. PubMed ID: 6609265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vesicular stomatitis virus oncolysis of T lymphocytes requires cell cycle entry and translation initiation.
    Oliere S; Arguello M; Mesplede T; Tumilasci V; Nakhaei P; Stojdl D; Sonenberg N; Bell J; Hiscott J
    J Virol; 2008 Jun; 82(12):5735-49. PubMed ID: 18417567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.